<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://quickmedreview.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Quick Med Review - Quick review of medical information</title>
 <link>http://quickmedreview.com</link>
 <description>To provide a quick review of medical information</description>
 <language>en</language>
<item>
 <title>Pyelonephritis</title>
 <link>http://quickmedreview.com/gu/pyelonephritis</link>
 <description>&lt;p&gt;Pyelonephritis refers to a upper urinary tract infection, versus &amp;quot;cystitis&amp;quot; seen in the lower urinary tract.  The most common organism is E. Coli, followed by Staph. saprophyticus.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Si/Sx&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;flank pain/CVA tenderness&lt;/li&gt;
&lt;li&gt;nausea, vomiting&lt;/li&gt;
&lt;li&gt;fever (&amp;gt; 38C)&lt;/li&gt;
&lt;li&gt;frequency, dysuria&lt;/li&gt;
&lt;li&gt;hematuria&lt;/li&gt;
&lt;li&gt;pyuria&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Dx&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Urinalysis (“UA”) signs indicative of pyelonephritis include:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;many WBC&lt;/li&gt;
&lt;li&gt;nitrite + (nitrite indicates organisms able to reduce nitrate to nitrite, and does not include certain organisms such as enterococci)&lt;/li&gt;
&lt;li&gt;esterase +&lt;/li&gt;
&lt;li&gt;white cell casts: rare, indicate a renal source for pyuria&lt;/li&gt;
&lt;li&gt;*note: the presence of epithelial cells indicates that the specimen was contaminated by contents outside the urinary tract.  Epithelial cells are not found in the urinary tract.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;A pelvic exam should be completed, as pelvic inflammatory disease is often confused with pyelonephritis.  A pregnancy test should also be completed if LMP is unknown.  Urine culture is also indicated, as resistance to empiric therapy may have serious sequelae.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Sequelae&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://quickmedreview.com/gu/pyelonephritis&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://quickmedreview.com/gu/pyelonephritis#comment</comments>
 <pubDate>Tue, 01 Aug 2006 20:19:32 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">167 at http://quickmedreview.com</guid>
</item>
<item>
 <title>Ischemia</title>
 <link>http://quickmedreview.com/cardiology/ekg/ischemia</link>
 <description>&lt;p&gt;Signs of ischemia include &amp;quot;QRST-T&amp;quot;&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Abnormal Q waves:&lt;/p&gt;
&lt;p&gt;-  defined as &amp;gt; 0.04 seconds (1 small box) and greater than 1/3 the height of the R wave&lt;/p&gt;
&lt;p&gt;- are normal in AVR, III?&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;T wave&lt;/p&gt;
&lt;p&gt;- T wave inversion (TWI) is normal in lead III, AVR, V1&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
</description>
 <comments>http://quickmedreview.com/cardiology/ekg/ischemia#comment</comments>
 <pubDate>Mon, 31 Jul 2006 15:29:54 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">165 at http://quickmedreview.com</guid>
</item>
<item>
 <title>Coumadin</title>
 <link>http://quickmedreview.com/pharmacology/cardiac_drugs/coumadin</link>
 <description>&lt;h2&gt;Mechanism&lt;/h2&gt;
&lt;p&gt;Prevents the liver synthesis of vitamin K dependent factors (2, 7, 9, 10)&lt;/p&gt;
&lt;h2&gt;Monitor&lt;/h2&gt;
&lt;p&gt;Coumadin (Warfarin) is monitored by PT, &amp;quot;WEPT&amp;quot;&lt;/p&gt;
&lt;h2&gt;Uses&lt;/h2&gt;
&lt;p&gt;Anticoagulation for: &lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;post myocardial infarction&lt;/li&gt;
&lt;li&gt;mechanical heart valves&lt;/li&gt;
&lt;li&gt;thrombosis prevention in atrial fibrillation&lt;/li&gt;
&lt;li&gt;post PE/DVT&lt;/li&gt;
&lt;/ol&gt;
</description>
 <comments>http://quickmedreview.com/pharmacology/cardiac_drugs/coumadin#comment</comments>
 <pubDate>Fri, 21 Jul 2006 18:30:20 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">164 at http://quickmedreview.com</guid>
</item>
<item>
 <title>Heparin - Low Molecular Weight</title>
 <link>http://quickmedreview.com/pharmacology/cardiac_drugs/heparin_low_molecular_weight</link>
 <description>&lt;h2&gt;Mechanism&lt;/h2&gt;
&lt;p&gt;Fractionated heparin that binds more specifically to factor X, LMWH has a better safety profile and does not require monitoring&lt;/p&gt;
&lt;h2&gt;Uses&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Myocardial infarct / Unstable angina&lt;/li&gt;
&lt;li&gt;Deep venous thrombosis / Pulmonary Embolus&lt;/li&gt;
&lt;/ol&gt;
&lt;h2&gt;Reversal&lt;/h2&gt;
&lt;p&gt;Also by protamine sulfate &lt;/p&gt;
</description>
 <comments>http://quickmedreview.com/pharmacology/cardiac_drugs/heparin_low_molecular_weight#comment</comments>
 <pubDate>Fri, 21 Jul 2006 18:24:08 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">163 at http://quickmedreview.com</guid>
</item>
<item>
 <title>Heparin</title>
 <link>http://quickmedreview.com/pharmacology/cardiac_drugs/heparin</link>
 <description>&lt;h2&gt;Mechanism&lt;/h2&gt;
&lt;p&gt;Binds antithrombin III, inactivates clotting factors IX, X, and XII.  Heparin will prevent new clots from forming, but does not lyse existing clots.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;h2&gt;Monitoring&lt;/h2&gt;
&lt;p&gt;PTT is used to monitor heparin, adequate dosing is roughly 1.5 to 2 times normal &lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;h2&gt;Reversal&lt;/h2&gt;
&lt;p&gt;Protamine Sulfate &lt;/p&gt;
</description>
 <comments>http://quickmedreview.com/pharmacology/cardiac_drugs/heparin#comment</comments>
 <pubDate>Fri, 21 Jul 2006 18:20:36 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">162 at http://quickmedreview.com</guid>
</item>
<item>
 <title>Digoxin</title>
 <link>http://quickmedreview.com/pharmacology/cardiac_drugs/digoxin</link>
 <description>&lt;h2&gt;Mechanism&lt;/h2&gt;
&lt;p&gt;Disrupts sodium-potasium ATP-ase in cardiac myocardium, resulting in&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Negative chronotropy&lt;/li&gt;
&lt;li&gt;Positive inotropy&lt;/li&gt;
&lt;/ol&gt;
&lt;h2&gt;Uses&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Rate control in &lt;a href=&quot;/cardiology/ep/atrial_fibrillation&quot;&gt;atrial fibrillation&lt;/a&gt;  &lt;/li&gt;
&lt;li&gt;To increase inotropy in LV dysfunction&lt;/li&gt;
&lt;/ol&gt;
&lt;h2&gt;Side Effects&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Overdose &lt;/li&gt;
&lt;/ol&gt;
</description>
 <comments>http://quickmedreview.com/pharmacology/cardiac_drugs/digoxin#comment</comments>
 <pubDate>Fri, 21 Jul 2006 18:16:03 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">161 at http://quickmedreview.com</guid>
</item>
<item>
 <title>Adenosine</title>
 <link>http://quickmedreview.com/pharmacology/cardiac_drugs/adenosine</link>
 <description>&lt;h2&gt;Mechanism&lt;/h2&gt;
&lt;p&gt;Causes AV nodal conduction block, short half-life (10 seconds)&lt;/p&gt;
&lt;h2&gt;Indications&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Diagnosis of supraventricular tachycardias &lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
</description>
 <comments>http://quickmedreview.com/pharmacology/cardiac_drugs/adenosine#comment</comments>
 <pubDate>Fri, 21 Jul 2006 18:12:27 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">160 at http://quickmedreview.com</guid>
</item>
<item>
 <title>Class IV Antidysrhythmics</title>
 <link>http://quickmedreview.com/pharmacology/cardiac_drugs/class_iv_antidysrhythmics</link>
 <description>&lt;p&gt;&lt;strong&gt;Mechanism&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Blockade of slow calcium channels &lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Examples&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Verapamil, Diltiazem &lt;/li&gt;
&lt;ul&gt;
&lt;li&gt;primarily affect heart, &amp;quot;give your heart VD&amp;quot;&lt;/li&gt;
&lt;/ul&gt;
&lt;li&gt;Nifedipine&lt;/li&gt;
&lt;ul&gt;
&lt;li&gt;primarily affect vessels&lt;/li&gt;
&lt;/ul&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Primary Uses&lt;/strong&gt;&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Dilt and verapamil: &lt;/li&gt;
&lt;ol&gt;
&lt;li&gt;to control ventricle in rapid a-fib (like Class II)&lt;/li&gt;
&lt;li&gt;to control ventricle in SVT&lt;/li&gt;
&lt;/ol&gt;
&lt;/ol&gt;
</description>
 <comments>http://quickmedreview.com/pharmacology/cardiac_drugs/class_iv_antidysrhythmics#comment</comments>
 <pubDate>Fri, 21 Jul 2006 14:00:21 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">159 at http://quickmedreview.com</guid>
</item>
<item>
 <title>Class III Antidysrhythmics</title>
 <link>http://quickmedreview.com/pharmacology/cardiac_drugs/class_iii_antidysrhythmics</link>
 <description>&lt;p&gt;&lt;strong&gt;Mechanism&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Sodium channel activation and potassium channel blockade &lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Examples&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Amiodarone, bretylium, sotalol, ibutilide&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Primary Uses&lt;/strong&gt;&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Ibutilide: to break new onset a-fib&lt;/li&gt;
&lt;/ol&gt;
</description>
 <comments>http://quickmedreview.com/pharmacology/cardiac_drugs/class_iii_antidysrhythmics#comment</comments>
 <pubDate>Fri, 21 Jul 2006 14:00:17 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">158 at http://quickmedreview.com</guid>
</item>
<item>
 <title>Class IC Antidysrhythmics</title>
 <link>http://quickmedreview.com/pharmacology/cardiac_drugs/class_ic_antidysrhythmics</link>
 <description>&lt;p&gt;&lt;strong&gt;Mechanism&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Large blockade sodium channel&lt;/p&gt;
&lt;p&gt;Prolong repolarization and action potential duration &lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Examples&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Propafenone, flecainide, encainide&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Primary Uses &lt;/strong&gt;&lt;/p&gt;
</description>
 <comments>http://quickmedreview.com/pharmacology/cardiac_drugs/class_ic_antidysrhythmics#comment</comments>
 <pubDate>Fri, 21 Jul 2006 14:00:12 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">157 at http://quickmedreview.com</guid>
</item>
</channel>
</rss>
